Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Cell Biol ; 9(5): 493-505, 2007 May.
Article in English | MEDLINE | ID: mdl-17450133

ABSTRACT

Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation - similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 - stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation - similar to those found in tumours bearing endogenous Kras2 mutations - induce cellular senescence that is Ink4a-Arf- dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53-Ink4a-Arf-dependent senescence checkpoints.


Subject(s)
Cell Transformation, Neoplastic/metabolism , Cellular Senescence , Epithelial Cells/metabolism , Mammary Glands, Animal/metabolism , Mammary Neoplasms, Experimental/metabolism , Oncogene Protein p21(ras)/metabolism , Precancerous Conditions/metabolism , ADP-Ribosylation Factors/metabolism , Animals , Cell Cycle Proteins/metabolism , Cell Proliferation , Cell Transformation, Neoplastic/drug effects , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Cellular Senescence/drug effects , Cellular Senescence/genetics , Cyclin-Dependent Kinase Inhibitor p16/metabolism , Dose-Response Relationship, Drug , Doxycycline/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/pathology , Female , Gene Expression Regulation, Neoplastic , Hyperplasia , Mammary Glands, Animal/drug effects , Mammary Glands, Animal/pathology , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Transgenic , Mutation , Oncogene Protein p21(ras)/genetics , Precancerous Conditions/genetics , Precancerous Conditions/pathology , Promoter Regions, Genetic/drug effects , Protein Transport , Receptors, Estrogen/metabolism , Receptors, Progesterone/metabolism , Signal Transduction , Time Factors , Tumor Suppressor Protein p53/metabolism , Up-Regulation
2.
Cancer Cell ; 8(3): 197-209, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16169465

ABSTRACT

Breast cancer recurrence is a fundamental clinical manifestation of tumor progression and represents the principal cause of death from this disease. Using a conditional transgenic mouse model for the recurrence of HER2/neu-induced mammary tumors, we demonstrate that the transcriptional repressor Snail is spontaneously upregulated in recurrent tumors in vivo and that recurrence is accompanied by epithelial-to-mesenchymal transition (EMT). Consistent with a causal role for Snail in these processes, we show that Snail is sufficient to induce EMT in primary tumor cells, that Snail is sufficient to promote mammary tumor recurrence in vivo, and that high levels of Snail predict decreased relapse-free survival in women with breast cancer. In aggregate, our observations strongly implicate Snail in the process of breast cancer recurrence.


Subject(s)
Mammary Neoplasms, Experimental/genetics , Neoplasm Recurrence, Local/genetics , Transcription Factors/genetics , Animals , Breast Neoplasms/genetics , Epithelial Cells/pathology , Female , Gene Expression Regulation, Neoplastic , Humans , Mammary Neoplasms, Experimental/pathology , Mesoderm/pathology , Mice , Mice, Transgenic , Neoplasm Recurrence, Local/pathology , Receptor, ErbB-2/genetics , Snail Family Transcription Factors , Transcription Factors/metabolism
3.
Cancer Cell ; 2(6): 451-61, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12498714

ABSTRACT

To determine the impact of tumor progression on the reversibility of Neu-induced tumorigenesis, we have used the tetracycline regulatory system to conditionally express activated Neu in the mammary epithelium of transgenic mice. When induced with doxycycline, bitransgenic MMTV-rtTA/TetO-NeuNT mice develop multiple invasive mammary carcinomas, essentially all of which regress to a clinically undetectable state following transgene deinduction. This demonstrates that Neu-initiated tumorigenesis is reversible. Strikingly, extensive lung metastases arising from Neu-induced mammary tumors also rapidly and fully regress following the abrogation of Neu expression. However, despite the near universal dependence of both primary tumors and metastases on Neu transgene expression, most animals bearing fully regressed Neu-induced tumors ultimately develop recurrent tumors that have progressed to a Neu-independent state.


Subject(s)
Adenocarcinoma/genetics , Cell Transformation, Neoplastic/genetics , Genes, erbB-2/genetics , Lung Neoplasms/secondary , Mammary Neoplasms, Experimental/genetics , Remission Induction/methods , Adenocarcinoma/pathology , Animals , Blotting, Northern , Down-Regulation , Doxycycline , Epithelium/physiology , Female , Gene Expression Regulation , Immunohistochemistry , In Situ Nick-End Labeling , Lung Neoplasms/pathology , Magnetic Resonance Imaging , Mammary Glands, Animal/physiology , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Transgenic , Models, Animal , Neoplasm Transplantation , Transgenes
SELECTION OF CITATIONS
SEARCH DETAIL
...